Clindamycin Phosphate Injection
Baxter Healthcare · Unavailable · Reason: Other
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 03/21/2023
- Package NDC
- 0338-3612-50
- Generic name
- Clindamycin Phosphate Injection
- Contact info
- 888-229-0001
- Availability
- Unavailable
- Related info
- Estimated recovery: October 2026
- Update date
- 09/17/2026
- Dosage form
- Injection
- Presentation
- Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)
- Company name
- Baxter Healthcare
- Shortage reason
- Other
- Status
- Current
- Therapeutic category
- Anti-Infective
- Harmonized identifiers (openFDA)
- Application number
- ANDA208084
- Brand name
- CLINDAMYCIN PHOSPHATE
- Generic name
- CLINDAMYCIN PHOSPHATE
- Manufacturer name
- Baxter Healthcare Company
- Product NDC
- 0338-3612, 0338-3410, 0338-3814
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- CLINDAMYCIN PHOSPHATE
- RxCUI
- 309335, 309336, 309339
- SPL ID
- c8906ab2-37d2-4fde-9784-0442bf7b9565
- SPL set ID
- 78832ac6-04c5-45e0-ae4d-f56d7920dda9
- Package NDC
- 0338-3410-50, 0338-3410-24, 0338-3612-50, 0338-3612-24, 0338-3814-50, 0338-3814-24
- UNII
- EH6D7113I8